Terms: = Pancreatic cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Diagnosis
4 results:
1. ATDC binds to KEAP1 to drive nrf2-mediated tumorigenesis and chemoresistance in pancreatic cancer.
Purohit V; Wang L; Yang H; Li J; Ney GM; Gumkowski ER; Vaidya AJ; Wang A; Bhardwaj A; Zhao E; Dolgalev I; Zamperone A; Abel EV; Magliano MPD; Crawford HC; Diolaiti D; Papagiannakopoulos TY; Lyssiotis CA; Simeone DM
Genes Dev; 2021 Feb; 35(3-4):218-233. PubMed ID: 33446568
[TBL] [Abstract] [Full Text] [Related]
2. Three novel genetic variants in nrf2 signaling pathway genes are associated with pancreatic cancer risk.
Yang W; Liu H; Duan B; Xu X; Carmody D; Luo S; Walsh KM; Abbruzzese JL; Zhang X; Chen X; Wei Q
Cancer Sci; 2019 Jun; 110(6):2022-2032. PubMed ID: 30972876
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological characteristics of anaplastic carcinoma of the pancreas with rhabdoid features.
Sano M; Homma T; Hayashi E; Noda H; Amano Y; Tsujimura R; Yamada T; Quattrochi B; Nemoto N
Virchows Arch; 2014 Nov; 465(5):531-8. PubMed ID: 25031015
[TBL] [Abstract] [Full Text] [Related]
4. Bile duct stents: is there an increased rate of complications in patients receiving chemotherapy?
Lofts FJ; Evans TR; Mansi JL; Glees JP; Knight MJ
Eur J Cancer; 1997 Feb; 33(2):209-13. PubMed ID: 9135490
[TBL] [Abstract] [Full Text] [Related]
